United States (US) Genetic Disorders Market (2025-2031) | Companies, Competitive Landscape, Size & Revenue, Trends, Industry, Outlook, Growth, Share, Value, Analysis, Forecast, Segmentation

Name: United States (US) Genetic Disorders Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Indication (CF, DMD, LSD, PNH), By Disease Type (Alzheimer's Disease, Cancer, Cystic fibrosis, Sickle Cell Anaemia, DMD, Thalassemia, Huntington's Disease) And Competitive Landscape

Product Code: ETC9966873	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Genetic Disorders Market Outlook
Market Size of United States (US) Genetic Disorders Market, 2024
Forecast of United States (US) Genetic Disorders Market, 2031
Historical Data and Forecast of United States (US) Genetic Disorders Revenues & Volume for the Period 2021- 2031
United States (US) Genetic Disorders Market Trend Evolution
United States (US) Genetic Disorders Market Drivers and Challenges
United States (US) Genetic Disorders Price Trends
United States (US) Genetic Disorders Porter's Five Forces
United States (US) Genetic Disorders Industry Life Cycle
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By CF for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By DMD for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By LSD for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By PNH for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Disease Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Alzheimer's Disease for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Cystic fibrosis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Sickle Cell Anaemia for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By DMD for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Thalassemia for the Period 2021- 2031
Historical Data and Forecast of United States (US) Genetic Disorders Market Revenues & Volume By Huntington's Disease for the Period 2021- 2031
United States (US) Genetic Disorders Import Export Trade Statistics
Market Opportunity Assessment By Indication
Market Opportunity Assessment By Disease Type
United States (US) Genetic Disorders Top Companies Market Share
United States (US) Genetic Disorders Competitive Benchmarking By Technical and Operational Parameters
United States (US) Genetic Disorders Company Profiles
United States (US) Genetic Disorders Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Genetic Disorders Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Genetic Disorders Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Genetic Disorders Market - Industry Life Cycle

3.4 United States (US) Genetic Disorders Market - Porter's Five Forces

3.5 United States (US) Genetic Disorders Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 United States (US) Genetic Disorders Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

4 United States (US) Genetic Disorders Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders in the US population

4.2.2 Technological advancements in genetic testing and precision medicine

4.2.3 Rising awareness and initiatives for genetic disorder screening and treatment

4.3 Market Restraints

4.3.1 High cost associated with genetic testing and treatment

4.3.2 Limited access to genetic counseling and specialized healthcare services

5 United States (US) Genetic Disorders Market Trends

6 United States (US) Genetic Disorders Market, By Types

6.1 United States (US) Genetic Disorders Market, By Indication

6.1.1 Overview and Analysis

6.1.2 United States (US) Genetic Disorders Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 United States (US) Genetic Disorders Market Revenues & Volume, By CF, 2021- 2031F

6.1.4 United States (US) Genetic Disorders Market Revenues & Volume, By DMD, 2021- 2031F

6.1.5 United States (US) Genetic Disorders Market Revenues & Volume, By LSD, 2021- 2031F

6.1.6 United States (US) Genetic Disorders Market Revenues & Volume, By PNH, 2021- 2031F

6.2 United States (US) Genetic Disorders Market, By Disease Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Genetic Disorders Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.2.3 United States (US) Genetic Disorders Market Revenues & Volume, By Cancer, 2021- 2031F

6.2.4 United States (US) Genetic Disorders Market Revenues & Volume, By Cystic fibrosis, 2021- 2031F

6.2.5 United States (US) Genetic Disorders Market Revenues & Volume, By Sickle Cell Anaemia, 2021- 2031F

6.2.6 United States (US) Genetic Disorders Market Revenues & Volume, By DMD, 2021- 2031F

6.2.7 United States (US) Genetic Disorders Market Revenues & Volume, By Thalassemia, 2021- 2031F

7 United States (US) Genetic Disorders Market Import-Export Trade Statistics

7.1 United States (US) Genetic Disorders Market Export to Major Countries

7.2 United States (US) Genetic Disorders Market Imports from Major Countries

8 United States (US) Genetic Disorders Market Key Performance Indicators

8.1 Number of genetic testing facilities and laboratories in the US

8.2 Adoption rate of precision medicine approaches in genetic disorder treatment

8.3 Percentage of the US population covered by insurance plans that include genetic testing and counseling

8.4 Research and development investment in genetic disorder therapies

8.5 Number of genetic disorder screening programs implemented nationwide

9 United States (US) Genetic Disorders Market - Opportunity Assessment

9.1 United States (US) Genetic Disorders Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 United States (US) Genetic Disorders Market Opportunity Assessment, By Disease Type, 2021 & 2031F

10 United States (US) Genetic Disorders Market - Competitive Landscape

10.1 United States (US) Genetic Disorders Market Revenue Share, By Companies, 2024

10.2 United States (US) Genetic Disorders Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Genetic Disorders Market

Estonia Genetic Disorders Market

Ethiopia Genetic Disorders Market

Fiji Genetic Disorders Market

Finland Genetic Disorders Market

Gabon Genetic Disorders Market

Global Genetic Disorders Market

Middle East Genetic Disorders Market

North America Genetic Disorders Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here